$LUMO
Lumos Pharma Inc

2013 Q1 Form 10-K Financial Statement

#000112623413000049 Filed on March 15, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2011 Q4 2011 Q3
Revenue $302.0K $301.0K $430.0K
YoY Change -35.88% -69.9% 7.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.000M $2.100M $1.100M
YoY Change 33.33% -8.7% -26.67%
% of Gross Profit
Research & Development $6.343M $4.000M $3.301M
YoY Change 65.61% 33.33% -15.36%
% of Gross Profit
Depreciation & Amortization $200.0K $200.0K $200.0K
YoY Change 14.29% -33.33% 100.0%
% of Gross Profit
Operating Expenses $8.344M $6.100M $4.402M
YoY Change 57.79% 15.09% -19.96%
Operating Profit -$8.042M -$5.804M -$3.972M
YoY Change 66.95%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $108.0K $0.00 -$14.00K
YoY Change -532.0% -114.0%
Pretax Income -$7.934M -$5.800M -$4.000M
YoY Change 65.29% 34.88% -21.57%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.934M -$5.810M -$3.986M
YoY Change 63.86% 41.71% -20.28%
Net Earnings / Revenue -2627.15% -1930.23% -926.98%
Basic Earnings Per Share -$0.33 -$0.44 -$1.09
Diluted Earnings Per Share -$0.33 -$3.867M -$1.09
COMMON SHARES
Basic Shares Outstanding 25.60M shares 20.66M shares 3.658M shares
Diluted Shares Outstanding 23.86M shares 3.658M shares

Balance Sheet

Concept 2013 Q1 2011 Q4 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $64.00M $42.00M $6.300M
YoY Change 78.77% 228.13%
Cash & Equivalents $63.28M $39.49M $6.287M
Short-Term Investments $700.0K $2.500M $0.00
Other Short-Term Assets $700.0K $400.0K $2.000M
YoY Change 133.33% -60.0%
Inventory
Prepaid Expenses $657.0K $409.0K
Receivables
Other Receivables
Total Short-Term Assets $65.77M $42.79M $8.900M
YoY Change 76.7% 192.23%
LONG-TERM ASSETS
Property, Plant & Equipment $5.889M $5.591M $5.100M
YoY Change -5.46% 2.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.889M $5.591M $5.100M
YoY Change -5.46% 2.85%
TOTAL ASSETS
Total Short-Term Assets $65.77M $42.79M $8.900M
Total Long-Term Assets $5.889M $5.591M $5.100M
Total Assets $71.66M $48.38M $14.00M
YoY Change 64.93% 140.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $865.0K $1.670M $300.0K
YoY Change 7.72% 202.54%
Accrued Expenses $2.015M $1.867M $1.700M
YoY Change 64.36% 20.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $177.0K $93.00K $6.200M
YoY Change 90.32% 2.2%
Total Short-Term Liabilities $3.141M $10.66M $9.100M
YoY Change 35.97% 226.62%
LONG-TERM LIABILITIES
Long-Term Debt $1.136M $900.0K $1.000M
YoY Change -83.54% -87.32%
Other Long-Term Liabilities $7.400M $0.00
YoY Change 393.33%
Total Long-Term Liabilities $8.520M $942.0K $1.000M
YoY Change 2.17% -86.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.141M $10.66M $9.100M
Total Long-Term Liabilities $8.520M $942.0K $1.000M
Total Liabilities $11.66M $11.61M $10.10M
YoY Change 9.5% 12.11%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $206.0K
YoY Change 472.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $60.00M $36.77M $3.900M
YoY Change
Total Liabilities & Shareholders Equity $71.66M $48.38M $14.00M
YoY Change 64.93% 140.96%

Cashflow Statement

Concept 2013 Q1 2011 Q4 2011 Q3
OPERATING ACTIVITIES
Net Income -$7.934M -$5.810M -$3.986M
YoY Change 63.86% 41.71% -20.28%
Depreciation, Depletion And Amortization $200.0K $200.0K $200.0K
YoY Change 14.29% -33.33% 100.0%
Cash From Operating Activities -$6.600M -$1.600M -$3.400M
YoY Change 17.02% -58.97% -10.53%
INVESTING ACTIVITIES
Capital Expenditures $62.00K -$200.0K $0.00
YoY Change -91.26% -100.0%
Acquisitions $0.00
YoY Change
Other Investing Activities $700.0K -$2.500M $300.0K
YoY Change 600.0% 257.14% -50.0%
Cash From Investing Activities $685.0K -$2.700M $200.0K
YoY Change -203.95% 285.71% -60.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$49.04M
YoY Change 37331.3%
Debt Paid & Issued, Net $37.00K
YoY Change 60.87%
Cash From Financing Activities $48.97M 37.50M 0.000
YoY Change 62676.92% 303.23% -100.0%
NET CHANGE
Cash From Operating Activities -6.600M -1.600M -3.400M
Cash From Investing Activities $685.0K -2.700M 200.0K
Cash From Financing Activities $48.97M 37.50M 0.000
Net Change In Cash $49.65M 33.20M -3.200M
YoY Change -898.12% 606.38% 18.52%
FREE CASH FLOW
Cash From Operating Activities -$6.600M -$1.600M -$3.400M
Capital Expenditures $62.00K -$200.0K $0.00
Free Cash Flow -$6.662M -$1.400M -$3.400M
YoY Change 4.93% -64.1% -8.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
196000 USD
CY2011Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
197000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1670000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
972000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1867000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1659000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2911000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2978000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118043000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
122514000 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3200000 USD
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2500000 USD
CY2010 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1500000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8500000 USD
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3752413 shares
CY2010 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11371090 shares
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3515051 shares
CY2012Q4 us-gaap Assets
Assets
29429000 USD
CY2011Q4 us-gaap Assets
Assets
48379000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
42788000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
23389000 USD
CY2011Q1 us-gaap Business Acquisition Equity Interest Issued Or Issuable Value Assigned
BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
8600000 USD
CY2010 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2011 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
481000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
53000 USD
CY2012 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
53000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
120000 USD
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
55000 USD
CY2011Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
121000 USD
CY2011Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
94000 USD
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
38000 USD
CY2012Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
516000 USD
CY2011Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
516000 USD
CY2011Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
379000 USD
CY2012Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
305000 USD
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
101000 USD
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
60000 USD
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Four
CapitalLeasesFutureMinimumPaymentsDueInRollingYearFour
4000 USD
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Three
CapitalLeasesFutureMinimumPaymentsDueInRollingYearThree
18000 USD
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due In Rolling Year Two
CapitalLeasesFutureMinimumPaymentsDueInRollingYearTwo
19000 USD
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
8000 USD
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Net Minimum Payments1
CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1
93000 USD
CY2011Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
137000 USD
CY2012Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
211000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10572000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39490000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20250000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15217000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20250000 USD
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4645000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28918000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-19240000 USD
CY2012Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
1494000 USD
CY2011Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
2490000 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
38833334 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
38833334 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20985192 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20591240 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20591240 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20985192 shares
CY2011Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
206000 USD
CY2012Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
210000 USD
CY2012 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, and certificates of deposit. Cash and cash equivalents are held by financial institutions and are federally insured up to certain limits. At times, the Company&#8217;s cash and cash equivalents balance exceeds the federally insured limits. To limit the credit risk, the Company invests its excess cash primarily in high quality securities such as money market funds. </font></div></div>
CY2010 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 USD
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
-449000 USD
CY2012 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 USD
CY2011 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 USD
CY2012Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
1500000 USD
CY2011Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
913000 USD
CY2012Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
84000 USD
CY2011Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
913000 USD
CY2011Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
0 USD
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1405000 USD
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
313000 USD
CY2011Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
0 USD
CY2011Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18919000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
23154000 USD
CY2011Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
61000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
17000 USD
CY2011Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16007000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19853000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2912000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2912000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
0 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
76000 USD
CY2011Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18858000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
23137000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
17000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
61000 USD
CY2010 us-gaap Depreciation And Amortization
DepreciationAndAmortization
655000 USD
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
687000 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
788000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3749000 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
104797000 USD
CY2011Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
81476000 USD
CY2011Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2012Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2000 USD
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2011Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.20
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2011Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.12
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.84
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.98
CY2012Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4300000 USD
CY2012 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 USD
CY2010 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 USD
CY2011 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0 USD
CY2011 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
31.25
CY2011 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
80000 USD
CY2010 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
282000 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
542000 USD
CY2012 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-11788000 USD
CY2012 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-2988000 USD
CY2010 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
CY2011 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-2269000 USD
CY2010 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
819000 USD
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
38000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
38000 USD
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7108000 USD
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6074000 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5679000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36943000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2010 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2010 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-528000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-260000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
637000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-700000 USD
CY2010 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
382000 USD
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
367000 USD
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
276000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3148000 USD
CY2012 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
0 USD
us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
350000 USD
CY2010 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-500000 USD
CY2011 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
0 USD
CY2010 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
797000 USD
CY2012 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-196000 USD
CY2011 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
416000 USD
CY2012 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-498000 USD
CY2011 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
550000 USD
CY2010 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-849000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-907000 USD
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
38000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
181000 USD
CY2011 us-gaap Interest Expense Debt
InterestExpenseDebt
42000 USD
CY2010 us-gaap Interest Expense Debt
InterestExpenseDebt
47000 USD
CY2012 us-gaap Interest Paid
InterestPaid
38000 USD
CY2011 us-gaap Interest Paid
InterestPaid
42000 USD
CY2010 us-gaap Interest Paid
InterestPaid
44000 USD
us-gaap Interest Paid
InterestPaid
142000 USD
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
11000 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
14000 USD
CY2010 us-gaap Investment Income Interest
InvestmentIncomeInterest
75000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1767000 USD
CY2011Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
4459000 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5085000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
11606000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
11502000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48379000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29429000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2919000 USD
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
93000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
149000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10664000 USD
CY2011Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
7200000 USD
CY2012Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1400000 USD
CY2011Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
942000 USD
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8583000 USD
CY2011 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
-8634000 USD
CY2005 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2278000 USD
CY2007 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
8000 USD
CY2008 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
-1000 USD
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11334000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42369000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1508000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120492000 USD
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2709000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-502000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10006000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-277000 USD
CY2010 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13270000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12949000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-20471000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-90236000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-23321000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-18087000 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-16213000 USD
us-gaap Net Income Loss
NetIncomeLoss
-104757000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-583000 USD
CY2011 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000 USD
CY2012 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2010 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-349000 USD
CY2011 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18087000 USD
CY2010 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-16213000 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23321000 USD
CY2010 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
99000 USD
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4000 USD
CY2010 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
468000 USD
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
505000 USD
CY2006 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
257000 USD
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2011Q4 us-gaap Notes Payable Current
NotesPayableCurrent
6000000 USD
CY2011 us-gaap Operating Expenses
OperatingExpenses
19934000 USD
us-gaap Operating Expenses
OperatingExpenses
115099000 USD
CY2010 us-gaap Operating Expenses
OperatingExpenses
18740000 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
24946000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-23259000 USD
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
-16661000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-18062000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-107695000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6301000 USD
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3892000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3972000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4817000 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6293000 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5804000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5848000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4394000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1317000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
484000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
29000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
170000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
193000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
441000 USD
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
601000 USD
CY2010 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
601000 USD
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
707000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
3700000 USD
CY2012Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
94500000 USD
CY2012 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-38000 USD
CY2011 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5000 USD
CY2010 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
71000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
320000 USD
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-62000 USD
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-26000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2355000 USD
CY2012 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2011 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
5000000 USD
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2012 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1992000 USD
CY2011 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2490000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
13282000 USD
CY2010 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
277000 USD
CY2010 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2011 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2010 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2932000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
281000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8092000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1323000 USD
CY2002 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
6000 USD
CY2011 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
8000 USD
CY2004 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
5000 USD
CY2005 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
82000 USD
CY2003 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
5000 USD
CY2006 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
4000 USD
CY2010 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
2000 USD
CY2012 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
0 USD
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
113000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2011Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
409000 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
907000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
42445000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37574000 USD
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1285000 USD
CY2010 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2082000 USD
CY2000 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
989000 USD
CY2009 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
40000 USD
CY2010 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
911000 USD
CY2011 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3479000 USD
CY2010 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
7723000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
67743000 USD
CY2011 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5000000 USD
CY2012 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
CY2010 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
911000 USD
CY2011 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
8215000 USD
CY2010 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1100000 USD
CY2012 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
456000 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
50000 USD
CY2010 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
50000 USD
CY2011 us-gaap Profit Loss
ProfitLoss
-18088000 USD
us-gaap Profit Loss
ProfitLoss
-105340000 USD
CY2010 us-gaap Profit Loss
ProfitLoss
-16562000 USD
CY2012 us-gaap Profit Loss
ProfitLoss
-23321000 USD
us-gaap Profit Loss
ProfitLoss
-64000 USD
CY2001 us-gaap Profit Loss
ProfitLoss
-1448000 USD
CY2002 us-gaap Profit Loss
ProfitLoss
-2253000 USD
CY2000 us-gaap Profit Loss
ProfitLoss
-236000 USD
CY2004 us-gaap Profit Loss
ProfitLoss
-3669000 USD
CY2005 us-gaap Profit Loss
ProfitLoss
-4770000 USD
CY2003 us-gaap Profit Loss
ProfitLoss
-2979000 USD
CY2008 us-gaap Profit Loss
ProfitLoss
-8842000 USD
CY2007 us-gaap Profit Loss
ProfitLoss
-7582000 USD
CY2006 us-gaap Profit Loss
ProfitLoss
-5318000 USD
CY2009 us-gaap Profit Loss
ProfitLoss
-10207000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
-6309000 USD
CY2011Q1 us-gaap Profit Loss
ProfitLoss
-3898000 USD
CY2012Q4 us-gaap Profit Loss
ProfitLoss
-6319000 USD
CY2011Q3 us-gaap Profit Loss
ProfitLoss
-3986000 USD
CY2011Q2 us-gaap Profit Loss
ProfitLoss
-4394000 USD
CY2011Q4 us-gaap Profit Loss
ProfitLoss
-5810000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
-5851000 USD
CY2012Q1 us-gaap Profit Loss
ProfitLoss
-4842000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
636000 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
710000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5591000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6040000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
327000 USD
CY2011 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
22000 USD
CY2012 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
35000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.12
CY2010 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
40000 USD
CY2011 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
7000 USD
CY2010 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0 USD
CY2012 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
409000 USD
CY2011 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
126000 USD
CY2012 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
122000 USD
CY2010 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
93000 USD
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
107000 USD
CY2010 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
67000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
476000 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
92000 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14255000 USD
CY2010 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12666000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17838000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
78156000 USD
CY2010 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
201000 USD
CY2012 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1629000 USD
CY2011 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2011 us-gaap Revenue From Grants
RevenueFromGrants
1872000 USD
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
1687000 USD
CY2010 us-gaap Revenue From Grants
RevenueFromGrants
2079000 USD
us-gaap Revenue From Grants
RevenueFromGrants
7404000 USD
CY2012Q2 us-gaap Revenue From Grants
RevenueFromGrants
590000 USD
CY2012Q4 us-gaap Revenue From Grants
RevenueFromGrants
299000 USD
CY2012Q1 us-gaap Revenue From Grants
RevenueFromGrants
471000 USD
CY2011Q2 us-gaap Revenue From Grants
RevenueFromGrants
537000 USD
CY2011Q1 us-gaap Revenue From Grants
RevenueFromGrants
604000 USD
CY2011Q3 us-gaap Revenue From Grants
RevenueFromGrants
430000 USD
CY2011Q4 us-gaap Revenue From Grants
RevenueFromGrants
301000 USD
CY2012Q3 us-gaap Revenue From Grants
RevenueFromGrants
327000 USD
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
1525000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8544000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
3195000 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
2545000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
6.88
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
3700000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
7800000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
2500000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2571041 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.34
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3600000 USD
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
82000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
194000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6992 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
86296 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
672079 shares
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1297738 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
664323 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.02
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3515051 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3752413 shares
CY2007 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000 USD
CY2010 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
82000 USD
CY2009 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000 USD
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.90
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
30800000 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.51
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.34
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.60
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.94
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.10
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
23500000 USD
us-gaap Stock Issued1
StockIssued1
1654000 USD
CY2012 us-gaap Stock Issued1
StockIssued1
0 USD
CY2011 us-gaap Stock Issued1
StockIssued1
0 USD
CY2010 us-gaap Stock Issued1
StockIssued1
932000 USD
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
341429 shares
CY2005 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
354000 USD
CY2006 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
130000 USD
CY2010 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
819000 USD
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
75390000 USD
CY2010 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
114000 USD
CY2012 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
239000 USD
CY2001 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
27000 USD
CY2000 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
47000 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37555000 USD
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
158000 USD
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000 USD
CY2009 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3000 USD
CY2002 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
14000 USD
CY2004 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
57000 USD
CY2003 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
15000 USD
CY2005 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
2000 USD
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3195000 USD
CY2011 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2545000 USD
CY2003 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
46000 USD
CY2005 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
51000 USD
CY2006 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22000 USD
CY2008 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
86000 USD
CY2007 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
58000 USD
CY2009 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
929000 USD
CY2010 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1525000 USD
CY2002 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
887000 USD
CY2003 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1112000 USD
CY2008 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36773000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
17927000 USD
CY1999Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
0 USD
CY2002Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2836000 USD
CY2000Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
776000 USD
CY2001Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-637000 USD
CY1999Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-37000 USD
CY2005Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10418000 USD
CY2004Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8252000 USD
CY2003Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4640000 USD
CY2008Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-31566000 USD
CY2006Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15331000 USD
CY2007Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-22833000 USD
CY2009Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-40786000 USD
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-52019000 USD
CY2012Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
2900000 USD
CY2011Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
160000 shares
CY2001 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
15000 USD
CY2012 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4000 USD
CY2010 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
469000 USD
CY2012 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (U.S.&#160;GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4300000 USD
CY2011 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3900000 USD
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20779450 shares
CY2010 nlnk Forgiveness Of Notes Receivable From Related Parties
ForgivenessOfNotesReceivableFromRelatedParties
350000 USD
CY2012 nlnk Forgiveness Of Notes Receivable From Related Parties
ForgivenessOfNotesReceivableFromRelatedParties
0 USD
CY2010 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3352331 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6064542 shares
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20779450 shares
CY2010 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3352331 shares
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6064542 shares
CY2010Q3 nlnk Accelerated Stock Payment Discount
AcceleratedStockPaymentDiscount
0.3
CY2010Q3 nlnk Accelerated Stock Payment Discount Shares
AcceleratedStockPaymentDiscountShares
74344 shares
CY2010Q3 nlnk Accelerated Stock Payment Fair Value
AcceleratedStockPaymentFairValue
819000 USD
CY2010Q3 nlnk Accelerated Stock Payment Shares
AcceleratedStockPaymentShares
173469 shares
CY2002 nlnk Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock
AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock
33000 USD
CY2000 nlnk Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock
AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock
13000 USD
CY2011 nlnk Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock
AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock
13000 USD
CY2003 nlnk Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock
AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock
7000 USD
CY2005 nlnk Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock
AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock
1000 USD
CY2004 nlnk Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock
AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock
5000 USD
CY2007 nlnk Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock
AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock
2000 USD
CY2010 nlnk Adjustments To Equity For Receipt Of Payment On Notes Receivable For Common Stock
AdjustmentsToEquityForReceiptOfPaymentOnNotesReceivableForCommonStock
146000 USD
CY2011Q1 nlnk Book Value Of Net Assets Acquired
BookValueOfNetAssetsAcquired
2900000 USD
CY2012Q4 nlnk Cash And Cash Equivalents Excluding Certificates Of Deposit
CashAndCashEquivalentsExcludingCertificatesOfDeposit
20250000 USD
CY2011Q4 nlnk Cash And Cash Equivalents Excluding Certificates Of Deposit
CashAndCashEquivalentsExcludingCertificatesOfDeposit
39490000 USD
CY2012 nlnk Current Common Stock Authorized
CurrentCommonStockAuthorized
38833334 shares
CY2012 nlnk Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition In Years
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognitionInYears
2.3
CY2010 nlnk Exercise Of Warrants
ExerciseOfWarrants
2000000 USD
CY2011 nlnk Financing Received
FinancingReceived
42600000 USD
CY2012 nlnk Financing Received
FinancingReceived
1300000 USD
nlnk Forgiveness Of Notes Receivable From Related Parties
ForgivenessOfNotesReceivableFromRelatedParties
350000 USD
CY2011 nlnk Forgiveness Of Notes Receivable From Related Parties
ForgivenessOfNotesReceivableFromRelatedParties
0 USD
CY2012 nlnk Greater Than10 Stockholder Iso Exercise Price Threshold
GreaterThan10StockholderIsoExercisePriceThreshold
1.1
CY2012 nlnk Greater Than10 Stockholder Iso Term
GreaterThan10StockholderIsoTerm
5
CY2011 nlnk Increase Decrease In State Research And Development Credit Receivable
IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable
28000 USD
CY2010 nlnk Increase Decrease In State Research And Development Credit Receivable
IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable
-60000 USD
nlnk Increase Decrease In State Research And Development Credit Receivable
IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable
-542000 USD
CY2012 nlnk Increase Decrease In State Research And Development Credit Receivable
IncreaseDecreaseInStateResearchAndDevelopmentCreditReceivable
-340000 USD
CY2012Q4 nlnk Intrinsic Value Price Per Share Base
IntrinsicValuePricePerShareBase
12.50
CY2012Q4 nlnk Intrinsic Value Unvested
IntrinsicValueUnvested
7300000 USD
CY2010 nlnk Iowa Refundable Research Credit
IowaRefundableResearchCredit
230000 USD
CY2011 nlnk Iowa Refundable Research Credit
IowaRefundableResearchCredit
160000 USD
CY2012 nlnk Iowa Refundable Research Credit
IowaRefundableResearchCredit
283000 USD
nlnk Iowa Refundable Research Credit
IowaRefundableResearchCredit
2100000 USD
CY2012 nlnk Ipo Price For Conversion Computations
IpoPriceForConversionComputations
7.00
CY2012 nlnk Iso Stockholder Ownership Threshold
IsoStockholderOwnershipThreshold
0.1
CY2011Q4 nlnk Lab Equipment
LabEquipment
3333000 USD
CY2012Q4 nlnk Lab Equipment
LabEquipment
3297000 USD
CY2012Q4 nlnk Lab Equipment Under Capital Lease
LabEquipmentUnderCapitalLease
489000 USD
CY2011Q4 nlnk Lab Equipment Under Capital Lease
LabEquipmentUnderCapitalLease
489000 USD
CY2011Q4 nlnk Leasehold Improvements Under Capital Lease
LeaseholdImprovementsUnderCapitalLease
27000 USD
CY2012Q4 nlnk Leasehold Improvements Under Capital Lease
LeaseholdImprovementsUnderCapitalLease
27000 USD
CY2012 nlnk Licensing Payments Under All In Licensing Agreements
LicensingPaymentsUnderAllInLicensingAgreements
255000 USD
nlnk Licensing Payments Under All In Licensing Agreements
LicensingPaymentsUnderAllInLicensingAgreements
2800000 USD
CY2011 nlnk Licensing Payments Under All In Licensing Agreements
LicensingPaymentsUnderAllInLicensingAgreements
89000 USD
CY2010 nlnk Licensing Payments Under All In Licensing Agreements
LicensingPaymentsUnderAllInLicensingAgreements
391000 USD
CY2012 nlnk Noncash Issuance Of Common Stock Dividend To Preferred Shareholders
NoncashIssuanceOfCommonStockDividendToPreferredShareholders
0 USD
CY2011 nlnk Noncash Issuance Of Common Stock Dividend To Preferred Shareholders
NoncashIssuanceOfCommonStockDividendToPreferredShareholders
1000 USD
nlnk Noncash Issuance Of Common Stock Dividend To Preferred Shareholders
NoncashIssuanceOfCommonStockDividendToPreferredShareholders
6000 USD
CY2010 nlnk Noncash Issuance Of Common Stock Dividend To Preferred Shareholders
NoncashIssuanceOfCommonStockDividendToPreferredShareholders
1000 USD
CY2011Q1 nlnk Options Issued In Acquisition
OptionsIssuedInAcquisition
50513 shares
CY2012 nlnk Pending Common Stock Authorized
PendingCommonStockAuthorized
75000000 shares
CY2011Q4 nlnk Post Ipo Converted Common Stock
PostIpoConvertedCommonStock
10719353 shares
CY2012 nlnk Pre Ipo Authorized Preferred Stock
PreIpoAuthorizedPreferredStock
17166666 shares
CY2012 nlnk Pre Ipo Blank Check Preferred
PreIpoBlankCheckPreferred
1388889 shares
CY2011Q4 nlnk Pre Ipo Convertible Preferred Stock
PreIpoConvertiblePreferredStock
14270113 shares
CY2012 nlnk Pre Ipo Par Value Of Blank Check Preferred
PreIpoParValueOfBlankCheckPreferred
0.01
CY2012 nlnk Pre Ipo Par Value Of Preferred Stock
PreIpoParValueOfPreferredStock
0.01
CY2011 nlnk Proceeds From Subsidiary Common Stock Option Exercise
ProceedsFromSubsidiaryCommonStockOptionExercise
0 USD
CY2012 nlnk Proceeds From Subsidiary Common Stock Option Exercise
ProceedsFromSubsidiaryCommonStockOptionExercise
0 USD
nlnk Proceeds From Subsidiary Common Stock Option Exercise
ProceedsFromSubsidiaryCommonStockOptionExercise
0 USD
CY2010 nlnk Proceeds From Subsidiary Common Stock Option Exercise
ProceedsFromSubsidiaryCommonStockOptionExercise
121000 USD
CY2011Q1 nlnk Reduction Of Additional Paid In Capital
ReductionOfAdditionalPaidInCapital
5700000 USD
CY2012 nlnk Reduction Of Ipo Offering Costs
ReductionOfIpoOfferingCosts
158000 USD
nlnk Reduction Of Ipo Offering Costs
ReductionOfIpoOfferingCosts
158000 USD
nlnk Repayments Advances Of Notes Receivable For Common Stock
RepaymentsAdvancesOfNotesReceivableForCommonStock
0 USD
CY2011 nlnk Repayments Advances Of Notes Receivable For Common Stock
RepaymentsAdvancesOfNotesReceivableForCommonStock
-13000 USD
CY2012 nlnk Repayments Advances Of Notes Receivable For Common Stock
RepaymentsAdvancesOfNotesReceivableForCommonStock
0 USD
CY2010 nlnk Repayments Advances Of Notes Receivable For Common Stock
RepaymentsAdvancesOfNotesReceivableForCommonStock
-25000 USD
CY2012 nlnk Reverse Split Denominator
ReverseSplitDenominator
1 shares
CY2012 nlnk Reverse Split Numerator
ReverseSplitNumerator
2.1 shares
CY2012Q4 nlnk Royalty Obligation Payable Noncurrent
RoyaltyObligationPayableNoncurrent
6000000 USD
CY2011Q4 nlnk Royalty Obligation Payable Noncurrent
RoyaltyObligationPayableNoncurrent
0 USD
CY2011Q1 nlnk Series E Preferred Issued In Acquisition
SeriesEPreferredIssuedInAcquisition
276304 shares
CY2011 nlnk Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMinimum
0
CY2010 nlnk Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMinimum
0
CY2012 nlnk Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateMinimum
0
CY2012Q4 nlnk Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Vesting Term In Years
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageVestingTermInYears
7.2
CY2012Q4 nlnk Share Based Compensation Shares Authorized Under Stock Option Plans Exercisable Options Weighted Average Vesting Term In Years
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisableOptionsWeightedAverageVestingTermInYears
6.7
CY2011Q4 nlnk State Research And Development Credit Receivable
StateResearchAndDevelopmentCreditReceivable
202000 USD
CY2012Q4 nlnk State Research And Development Credit Receivable
StateResearchAndDevelopmentCreditReceivable
542000 USD
CY2008 nlnk Stock Issued For Licensing
StockIssuedForLicensing
5000 USD
CY2010 nlnk Stock Issued For Licensing
StockIssuedForLicensing
201000 USD
CY2010 nlnk Stock Issued For Licensing Shares
StockIssuedForLicensingShares
23810 shares
CY2012 nlnk Tenant Improvement Allowance
TenantImprovementAllowance
622000 USD
CY2011Q4 nlnk Total Leasehold Improvements And Equipment
TotalLeaseholdImprovementsAndEquipment
8502000 USD
CY2012Q4 nlnk Total Leasehold Improvements And Equipment
TotalLeaseholdImprovementsAndEquipment
9018000 USD
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q4
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0001126234
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25602804 shares
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2012Q2 dei Entity Public Float
EntityPublicFloat
194431787 USD
CY2012 dei Entity Registrant Name
EntityRegistrantName
NEWLINK GENETICS CORP
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0001126234-13-000049-index-headers.html Edgar Link pending
0001126234-13-000049-index.html Edgar Link pending
0001126234-13-000049.txt Edgar Link pending
0001126234-13-000049-xbrl.zip Edgar Link pending
alphagal.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
isurplogo.jpg Edgar Link pending
logo.jpg Edgar Link pending
nlnk-20121231.xml Edgar Link completed
nlnk-20121231.xsd Edgar Link pending
nlnk-2012123110kchart.jpg Edgar Link pending
nlnk-20121231x10k.htm Edgar Link pending
nlnk-20121231xex101.htm Edgar Link pending
nlnk-20121231xex102.htm Edgar Link pending
nlnk-20121231xex103.htm Edgar Link pending
nlnk-20121231xex311.htm Edgar Link pending
nlnk-20121231xex312.htm Edgar Link pending
nlnk-20121231xex321.htm Edgar Link pending
nlnk-20121231_cal.xml Edgar Link unprocessable
nlnk-20121231_def.xml Edgar Link unprocessable
nlnk-20121231_lab.xml Edgar Link unprocessable
nlnk-20121231_pre.xml Edgar Link unprocessable
nomogramimage1.gif Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending